Platinum-based chemotherapy plus cetuximab for the first-line treatment of Japanese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: results of a phase II trial.
about
G-Protein-Coupled Receptors: Next Generation Therapeutic Targets in Head and Neck Cancer?Combination of Sonodynamic and Photodynamic Therapy against Cancer Would Be Effective through Using a Regulated Size of Nanoparticles.Feasibility of cisplatin/5-fluorouracil and panitumumab in Japanese patients with squamous cell carcinoma of the head and neck.Cetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: a retrospective study in a single comprehensive European cancer institution.Recent multidisciplinary approach with molecular targeted drugs for advanced head and neck cancer.Targeted treatment of head and neck squamous-cell carcinoma: potential of lapatinib.Collagen gel droplet-embedded culture drug sensitivity testing in hard palate cancer-predicted antitumor efficacy of cetuximab: A case report.Retrospective analysis of premedication, glucocorticosteroids, and H1-antihistamines for preventing infusion reactions associated with cetuximab treatment of patients with head and neck cancerThe EGFR Inhibitor Gefitinib Enhanced the Response of Human Oral Squamous Cell Carcinoma to Cisplatin In Vitro.Superselective intraarterial cerebral infusion of cetuximab after osmotic blood/brain barrier disruption for recurrent malignant glioma: phase I study.Anti-podocalyxin antibody exerts antitumor effects via antibody-dependent cellular cytotoxicity in mouse xenograft models of oral squamous cell carcinoma.Mild pulmonary emphysema a risk factor for interstitial lung disease when using cetuximab for squamous cell carcinoma of the head and neck
P2860
Q26801162-AA1D1146-AD41-4B0C-8BEE-8E2FEE0FB0E7Q30364639-D8AADD60-B9F9-4C02-A606-41338C354B70Q33807021-92490C3C-0ED5-440C-A559-7A3825F1F2D7Q35091386-C2F852F5-51F1-4685-9ADF-16C9C44B55FDQ38191864-65F1AD2A-2CF4-4682-86FA-F7A780B20AAAQ38194548-DB56321F-C402-4B99-A38A-C1A935D94ECAQ41542263-E9748F8D-A6F4-4D6F-B962-887F9CA1F98AQ42245331-A0738DE4-CCCE-4DE4-A95F-59E18222719DQ45065769-6ED651E6-D7F0-496E-B73B-22800DA78B08Q48858178-E36B9D5C-10D5-4274-B4B3-03B1424087A9Q55249763-15003FA8-90F0-4633-B437-338E83BED7B7Q58171843-E89926EA-874D-47C1-8DE9-2B85526564EB
P2860
Platinum-based chemotherapy plus cetuximab for the first-line treatment of Japanese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: results of a phase II trial.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Platinum-based chemotherapy pl ...... : results of a phase II trial.
@ast
Platinum-based chemotherapy pl ...... : results of a phase II trial.
@en
type
label
Platinum-based chemotherapy pl ...... : results of a phase II trial.
@ast
Platinum-based chemotherapy pl ...... : results of a phase II trial.
@en
prefLabel
Platinum-based chemotherapy pl ...... : results of a phase II trial.
@ast
Platinum-based chemotherapy pl ...... : results of a phase II trial.
@en
P2093
P2860
P921
P356
P1476
Platinum-based chemotherapy pl ...... : results of a phase II trial.
@en
P2093
Akihiro Homma
Barbara de Blas
Frank Beier
Kenji Okami
Makoto Tahara
Masato Fujii
Nobuya Monden
Shunji Takahashi
Takahide Taguchi
Takayuki Yoshino
P2860
P304
P356
10.1093/JJCO/HYT034
P577
2013-03-10T00:00:00Z